Delhi's Sir Gangaram hospital on Tuesday started carrying out monoclonal antibody therapy, which is believed to reduce chance of hospitalisation for COVID-19 patients by 70 per cent.
The positivity rate in the national capital also fell below one per cent for the second consecutive day. The positivity rate is now 0.88 percent.
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16.
The BHU research has come amid reports that the government is mulling to tweak its vaccination strategy.
The trust, founded by like-minded youngsters, has served over 3500 meals in three weeks. Hundreds of food packets are distributed daily outside Lucknow's King George's Medical University (KGMU) hospital to the attendees of patients as well.
Delhi on Monday reported 648 new coronavirus cases, the lowest in two and a half months. At least 86 people died in the last 24 hours, according to the latest health bulletin. The positivity rate in the national capital also fell below one per cent, the first time since March 19.
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V – the world’s first registered vaccine against coronavirus.
The Centre on Monday told Supreme Court that entire eligible population will be vaccinated against Covid-19 by 2021-end.
India's COVID-19 tally had crossed the 20 lakh-mark on August 7 last, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16.
In order to ramp up vaccine production as the country battles the second wave of coronavirus, the Centre has decided to support some PSU companies with grants under 'Mission COVID Suraksha'.
Delhi recorded as many as 1,141 fresh coronavirus cases on Friday. With this, the tally of COVID-19 cases in the national capital has reached over 14.23 lakh, while the death toll mounted to 23,951.
The Ministry of Health and Family Welfare on Friday said that India's active caseload shows a declining trend as cases further dipped to 23,43,152 and active cases decreased by 76,755 in the last 24 hours.
The price of DRDO’s 2DG anti-COVID 19 drug has been fixed at Rs 990 per sachet by Dr Reddy’s lab.
Seeking a fast-track approval for its COVID-19 vaccine, US major Pfizer has told Indian authorities that its jab has shown "high effectiveness" against the SARS-CoV-2 variant prevalent in India and on people of Indian ethnicity or nationality, while it is suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees, sources said on Wednesday.
Delhi on Wednesday reported 1,491 new Covid-19 cases, the lowest since March 25 when the national capital had reported a single-day tally of 1,515 cases, according to the health bulletin issued by the Delhi government.
Scientists have developed two new drugs to both prevent the COVID-19 infection, and also treat people who have been exposed to the novel coronavirus so that they do not develop severe disease.
Moderna has conveyed to Indian authorities that it does not have surplus vaccines to share in 2021.
Delhi recorded as many as 1,568 fresh coronavirus cases on Tuesday. With this, the tally of COVID-19 cases in the national capital has reached over 14.19 lakh, while the death toll mounted to 23,565.
Bharat Biotech is a Hyderabad-based biotechnology company. Its Covid-19 vaccine, Covaxin, is currently being used for inoculation in India.
RDIF and Panacea Biotec have launched the production of Sputnik V vaccine in India. India's Panacea Biotec will now produce 100 million doses of Sputnik V per year.
Top News
Latest News
